A case of dual-mechanism immune-related anaemia in a patient with metastatic melanoma treated with nivolumab and ipilimumab
Crossref DOI link: https://doi.org/10.1136/jitc-2019-000380
Published Online: 2020-03-12
Published Print: 2020-03
Update policy: https://doi.org/10.1136/crossmarkpolicy
Olson, Daniel J https://orcid.org/0000-0001-8902-7661
Rajagopal, Padma
Tjota, Melissa Y
Venkataraman, Girish
Luke, Jason J
Gajewski, Thomas F
Funding for this research was provided by:
Clinical Therapeutics Training Grant (T32GM007019)
License valid from 2020-03-12
